These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23845462)

  • 1. The use of systemic therapies for the treatment of brain metastases in metastatic melanoma: opportunities and unanswered questions.
    Murrell J; Board R
    Cancer Treat Rev; 2013 Dec; 39(8):833-8. PubMed ID: 23845462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune checkpoint blockade in patients with melanoma metastatic to the brain.
    Di Giacomo AM; Margolin K
    Semin Oncol; 2015 Jun; 42(3):459-65. PubMed ID: 25965364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic therapies for melanoma brain metastases: which drug for whom and when?
    Ramanujam S; Schadendorf D; Long GV
    Chin Clin Oncol; 2015 Jun; 4(2):25. PubMed ID: 26112811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of melanoma brain metastases: a new paradigm.
    Carlino MS; Fogarty GB; Long GV
    Cancer J; 2012; 18(2):208-12. PubMed ID: 22453023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug delivery to melanoma brain metastases: Can current challenges lead to new opportunities?
    Gampa G; Vaidhyanathan S; Sarkaria JN; Elmquist WF
    Pharmacol Res; 2017 Sep; 123():10-25. PubMed ID: 28634084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting brain metastases in patients with melanoma.
    Papadatos-Pastos D; Soultati A; Harries M
    Biomed Res Int; 2013; 2013():186563. PubMed ID: 24455677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting the role of systemic therapies in patients with metastatic melanoma to the CNS.
    Papadatos-Pastos D; Januszewski A; Dalgleish A
    Expert Rev Anticancer Ther; 2013 May; 13(5):559-67. PubMed ID: 23617347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of response and progression in patients with BRAF-mutant melanoma metastatic to the brain who were treated with dabrafenib.
    Azer MW; Menzies AM; Haydu LE; Kefford RF; Long GV
    Cancer; 2014 Feb; 120(4):530-6. PubMed ID: 24496868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of systemic therapies in the management of melanoma brain metastases.
    Lyle M; Long GV
    Curr Opin Oncol; 2014 Mar; 26(2):222-9. PubMed ID: 24434634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of brain metastases from melanoma.
    McWilliams RR; Brown PD; Buckner JC; Link MJ; Markovic SN
    Mayo Clin Proc; 2003 Dec; 78(12):1529-36. PubMed ID: 14661682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma-induced brain metastases.
    McWilliams RR; Rao RD; Buckner JC; Link MJ; Markovic S; Brown PD
    Expert Rev Anticancer Ther; 2008 May; 8(5):743-55. PubMed ID: 18471047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic strategies and systemic treatment of brain melanoma metastases].
    Durando X; Mansard S; Daste A; Gimbergues P; Brocard L; Magné N; Thivat E
    Bull Cancer; 2013 Jan; 100(1):23-8. PubMed ID: 22889847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma in the brain: biology and therapeutic options.
    Gibney GT; Forsyth PA; Sondak VK
    Melanoma Res; 2012 Jun; 22(3):177-83. PubMed ID: 22495668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete regression of a previously untreated melanoma brain metastasis with ipilimumab.
    Schartz NE; Farges C; Madelaine I; Bruzzoni H; Calvo F; Hoos A; Lebbé C
    Melanoma Res; 2010 Jun; 20(3):247-50. PubMed ID: 20216240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Melanoma brain metastases : Treatment options].
    Rauschenberg R; Tabatabai G; Troost EG; Garzarolli M; Beissert S; Meier F
    Hautarzt; 2016 Jul; 67(7):536-43. PubMed ID: 27206449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New therapeutical strategies in the treatment of metastatic disease.
    Julia F; Thomas L; Dalle S
    Dermatol Ther; 2012; 25(5):452-7. PubMed ID: 23046024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of brain metastases in patients with metastatic melanoma while receiving ipilimumab.
    Frenard C; Peuvrel L; Jean MS; Brocard A; Knol AC; Nguyen JM; Khammari A; Quereux G; Dreno B
    J Neurooncol; 2016 Jan; 126(2):355-60. PubMed ID: 26511495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS).
    Samlowski WE; Watson GA; Wang M; Rao G; Klimo P; Boucher K; Shrieve DC; Jensen RL
    Cancer; 2007 May; 109(9):1855-62. PubMed ID: 17351953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of thalidomide in patients with brain metastases from malignant melanoma.
    Vestermark LW; Larsen S; Lindeløv B; Bastholt L
    Acta Oncol; 2008; 47(8):1526-30. PubMed ID: 18607876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment options for brain metastases from melanoma.
    McWilliams RR; Rao RD; Brown PD; Link MJ; Buckner JC
    Expert Rev Anticancer Ther; 2005 Oct; 5(5):809-20. PubMed ID: 16221051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.